查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1936772

2026-2034年全球心臟再同步治療設備市場規模、佔有率、趨勢和成長分析報告

Global Cardiac Resynchronization Therapy Devices Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 112 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計心臟再同步治療（CRT）設備市場規模將從 2025 年的 55.3 億美元成長到 2034 年的 89.3 億美元，2026 年至 2034 年的複合年成長率為 5.47%。

由於心臟衰竭盛行率不斷上升以及人們對先進治療方案的認知度日益提高，全球心臟再同步治療（CRT）設備市場預計將迎來顯著成長。 CRT設備，包括心律調節器和植入式心臟整流去顫器（ICD），旨在改善心臟衰竭患者的心臟和心臟功能。隨著醫療機構尋求有效治療心臟疾病的解決方案，CRT設備的應用預計將顯著增加，從而推動這一重要市場的創新和投資。

此外，CRT技術的進步和設備設計的創新預計將進一步推動市場成長。新一代CRT設備的研發，例如具備遠端監測功能和更長電池續航力等增強特性，有助於改善患者的治療效果和便利性。此外，對個人化醫療和以病人為中心的照護的日益重視，也推動了對可根據患者個別需求量身定做的CRT設備的需求。隨著醫療保健格局的不斷演變，心臟再同步治療設備市場預計將迎來對能夠改善患者照護和生活品質的創新解決方案的激增。

此外，對監管合規性和臨床證據的日益重視也將塑造CRT設備市場的未來。隨著監管機構實施更嚴格的設備核准和監管指南，對符合這些標準的CRT設備的需求將持續成長。設備製造商、醫療服務提供者和監管機構之間的合作對於推動這些進步至關重要，並確保心臟再同步治療設備市場始終處於心血管創新領域的前沿。

目錄

第1章 引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 繪製滲透率和成長前景圖
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制
    • 市場機遇
    • 市場問題
  • 波特五力分析
  • PESTLE分析

4. 全球心臟再同步治療設備市場（依產品分類）

  • 市場分析、洞察與預測
  • CRT去心房顫動
  • CRT心律調節器

5. 全球心臟再同步治療設備市場（依最終用途分類）

  • 市場分析、洞察與預測
  • 醫院
  • 心臟中心
  • 其他

6. 全球心臟再同步治療設備市場（依地區分類）

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第7章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商格局（基於現有資訊）
  • 策略規劃

第8章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Medtronic
    • Abbott
    • Boston Scientific Corporation
    • Biotronik SE & Co. KG
    • MicroPort Scientific Corporation
    • LivaNova Plc
    • Asahi Kasei Medical Co.Ltd
    • Nihon Kohden Corporation
    • Schiller AG
    • Medico SPA
簡介目錄
Product Code: VMR11212560

The Cardiac Resynchronization Therapy Devices Market size is expected to reach USD 8.93 Billion in 2034 from USD 5.53 Billion (2025) growing at a CAGR of 5.47% during 2026-2034.

The global cardiac resynchronization therapy (CRT) devices market is poised for significant growth, driven by the increasing prevalence of heart failure and the growing awareness of advanced treatment options. CRT devices, which include pacemakers and implantable cardioverter-defibrillators, are designed to improve the heart's rhythm and function in patients with heart failure. As healthcare providers seek effective solutions to manage heart conditions, the adoption of CRT devices is expected to rise substantially, fostering innovation and investment in this critical market.

Moreover, advancements in CRT technology and device design are anticipated to further boost market growth. The development of next-generation CRT devices with enhanced features, such as remote monitoring capabilities and improved battery life, is enhancing patient outcomes and convenience. Additionally, the growing emphasis on personalized medicine and patient-centered care is driving the demand for CRT devices that can be tailored to individual patient needs. As the healthcare landscape continues to evolve, the market for cardiac resynchronization therapy devices is likely to witness a surge in demand for innovative solutions that improve patient care and quality of life.

In addition, the increasing focus on regulatory compliance and clinical evidence is expected to shape the future of the CRT devices market. As regulatory bodies implement stricter guidelines for device approval and monitoring, the demand for CRT devices that meet these standards will continue to rise. Collaborative efforts between device manufacturers, healthcare providers, and regulatory agencies will be essential in driving these advancements, ensuring that the cardiac resynchronization therapy devices market remains at the forefront of cardiovascular innovation.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

  • CRT-Defibrillator
  • CRT-Pacemaker

By End-use

  • Hospital
  • Cardiac Center
  • Others

COMPANIES PROFILED

  • Medtronic, Abbott, Boston Scientific Corporation, Biotronik SE Co KG, MicroPort Scientific Corporation, LivaNova plc, Asahi Kasei Medical Co, Ltd, Nihon Kohden Corporation, Schiller AG, Medico SpA

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. CRT-Defibrillator Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. CRT-Pacemaker Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET: BY END-USE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast End-use
  • 5.2. Hospital Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Cardiac Center Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CARDIAC RESYNCHRONIZATION THERAPY DEVICES MARKET: BY REGION 2022-2034(USD MN)

  • 6.1. Regional Outlook
  • 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.2.1 By Product
    • 6.2.2 By End-use
    • 6.2.3 United States
    • 6.2.4 Canada
    • 6.2.5 Mexico
  • 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.3.1 By Product
    • 6.3.2 By End-use
    • 6.3.3 United Kingdom
    • 6.3.4 France
    • 6.3.5 Germany
    • 6.3.6 Italy
    • 6.3.7 Russia
    • 6.3.8 Rest Of Europe
  • 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.4.1 By Product
    • 6.4.2 By End-use
    • 6.4.3 India
    • 6.4.4 Japan
    • 6.4.5 South Korea
    • 6.4.6 Australia
    • 6.4.7 South East Asia
    • 6.4.8 Rest Of Asia Pacific
  • 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.5.1 By Product
    • 6.5.2 By End-use
    • 6.5.3 Brazil
    • 6.5.4 Argentina
    • 6.5.5 Peru
    • 6.5.6 Chile
    • 6.5.7 South East Asia
    • 6.5.8 Rest of Latin America
  • 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 6.6.1 By Product
    • 6.6.2 By End-use
    • 6.6.3 Saudi Arabia
    • 6.6.4 UAE
    • 6.6.5 Israel
    • 6.6.6 South Africa
    • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

  • 7.1. Recent Developments
  • 7.2. Company Categorization
  • 7.3. Supply Chain & Channel Partners (based on availability)
  • 7.4. Market Share & Positioning Analysis (based on availability)
  • 7.5. Vendor Landscape (based on availability)
  • 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL CARDIAC RESYNCHRONIZATION THERAPY DEVICES INDUSTRY

  • 8.1. Top Companies Market Share Analysis
  • 8.2. Company Profiles
    • 8.2.1 Medtronic
    • 8.2.2 Abbott
    • 8.2.3 Boston Scientific Corporation
    • 8.2.4 Biotronik SE & Co. KG
    • 8.2.5 MicroPort Scientific Corporation
    • 8.2.6 LivaNova Plc
    • 8.2.7 Asahi Kasei Medical Co.Ltd
    • 8.2.8 Nihon Kohden Corporation
    • 8.2.9 Schiller AG
    • 8.2.10 Medico S.P.A